Genetic analysis and phylogenetic characterization of pandemic (H1N1) 2009 influenza viruses that found in Nagasaki, Japan

Japanese Journal of Infectious Diseases

Volumn 64, Issue 3, 2011, Pages 195-203

  Kawano, Hiroaki ^a   Haruyama, Takahiro ^a   Hayashi, Yuji ^a   Sinoda, Yoshinori ^a   Sonoda, Megumi ^a   Kobayashi, Nobuyuki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL RESISTANCE; ARTICLE; CELL STRAIN; CHILD; CLUSTER ANALYSIS; CONTROLLED STUDY; DOG; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DRIFT; GEOGRAPHIC ORIGIN; HUMAN; INFANT; INFLUENZA VIRUS A H1N1; JAPAN; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHILIPPINES; PHYLOGENY; PRESCHOOL CHILD; SCHOOL CHILD; SEQUENCE ALIGNMENT; STRAIN DIFFERENCE; VIRUS ISOLATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; GENOTYPE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; JAPAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEURAMINIDASE; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VIRAL PROTEINS; YOUNG ADULT;

EID: 79958024297     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention (2009): Update: novel influenza A (H1N1) virus infections-worldwide. Morbid. Mortal. Wkly. Rep., 58, 453-458.
2. Ministry of Health, Labour and Welfare, Japan. Online at http://www.mhlw.go.jp/kinkyu/kenkou/influenza/090429-02.html (in Japanese).
3. Ono, H. (2009): Emergency response to pandemic (H1N1) 2009 at the Narita Airport Quarantine Station, April-June 2009. Infect. Agents Surveillance Rep., 30, 257-258 (in Japanese).
4. Caton, A.J., Brownlee, G.G., Yewdell, J.W., et al. (1982): The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell, 31, 417-427.
5. Wilson, I.A., Skehel, J.J. and Wiley, D.C. (1981): Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature, 289, 366-373.
6. Luoh, S.M., McGregor, M.W. and Hinshaw, V.S. (1992): Hemagglutinin mutations related to antigenic variation in H1 swine influenza viruses. J. Virol., 66, 1066-1073.
7. Fitch, W.M., Bush, R.M., Bender, C.A., et al. (1997): Long term trends in the evolution of H (3) HA1 human influenza type A. Proc. Natl. Acad. Sci. USA, 94, 7712-7718.
8. Fitch, W.M., Bush, R.M., Bender, C.A., et al. (2000): The Wilhelmine E. Key 1999 Invitational lecture. Predicting the evolution of human influenza A. J. Hered., 91, 183-185.
9. Varghese, J.N., Laver, W.G. and Colman, P.M. (1983): Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution. Nature, 303, 35-40.
10. Moscona, A. (2005): Neuraminidase inhibitors for influenza. N. Engl. J. Med., 353, 1363-1373.
11. McKimm-Breschkin, J., Trivedi, T., Hampson, A., et al. (2003): Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob. Agents Chemother., 47, 2264-2272.
12. Tamura, D., Mitamura, K., Yamazaki, M., et al. (2009): Oseltamivir- resistant influenza a viruses circulating in Japan. J. Clin. Microbiol., 47, 1424-1427.
13. de Jong, M.D., Tran, T.T., Truong, H.K., et al. (2005): Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med., 353, 2667-2672.
14. World Health Organization (2009): Influenza A (H1N1) Virus Resistance to Oseltamivir. 21 March 2009. Online at http://www.who.int/csr/disease/influenza/h1n1_table/en/index.html.
15. Ujike, M., Shimabukuro, K., Mochizuki, K., et al. (2010): Oseltamivir- resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan. Emerg. Infect. Dis., 16, 926-935.
16. Galtier, N., Gouy, M. and Gautier, C. (1996): SEAVIEW and PHYLO_WIN: two graphic tools for sequence alignment and molecular phylogeny. Comput. Appl. Biosci., 12, 543-548.
17. Guindon, S. and Gascuel, O. (2003): A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol., 52, 696-704.
18. Tamura, K., Dudley, J., Nei, M., et al. (2007): MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol., 24, 1596-1599.
19. Igarashi, M., Ito, K., Kida, H., et al. (2008): Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin. Virology, 376, 323-329.
20. Klenk, H-D., Rott, R., Orlich, M., et al. (1975): Activation of influenza A viruses by trypsin treatment. Virology, 68, 426-439.
21. Lazarowitz, S.G. and Choppin, P.W. (1975): Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology, 68, 440-454.
22. Kawaoka, Y. and Webster, R.G. (1988): Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc. Natl. Acad. Sci. USA, 85, 324-328.
23. Itoh, Y., Shinya, K., Kiso, M., et al. (2009): In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature, 460, 1021-1025.
24. Igarashi, M., Ito, K., Yoshida, R., et al. (2009): Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One, 5, e8553.
25. Ives, J.A., Carr, J.A., Mendel, D.B., et al. (2002): The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res., 55, 307-317.